431 related articles for article (PubMed ID: 7664746)
21. Mutation at tyrosine in AMLRY (GILRY like) motif of yeast eRF1 on nonsense codons suppression and binding affinity to eRF3.
Akhmaloka ; Susilowati PE; Subandi ; Madayanti F
Int J Biol Sci; 2008 Apr; 4(2):87-95. PubMed ID: 18463713
[TBL] [Abstract][Full Text] [Related]
22. C-terminal domains of human translation termination factors eRF1 and eRF3 mediate their in vivo interaction.
Merkulova TI; Frolova LY; Lazar M; Camonis J; Kisselev LL
FEBS Lett; 1999 Jan; 443(1):41-7. PubMed ID: 9928949
[TBL] [Abstract][Full Text] [Related]
23. The GTP-binding release factor eRF3 as a key mediator coupling translation termination to mRNA decay.
Kobayashi T; Funakoshi Y; Hoshino S; Katada T
J Biol Chem; 2004 Oct; 279(44):45693-700. PubMed ID: 15337765
[TBL] [Abstract][Full Text] [Related]
24. Suppression of eukaryotic translation termination by selected RNAs.
Carnes J; Frolova L; Zinnen S; Drugeon G; Phillippe M; Justesen J; Haenni AL; Leinwand L; Kisselev LL; Yarus M
RNA; 2000 Oct; 6(10):1468-79. PubMed ID: 11073222
[TBL] [Abstract][Full Text] [Related]
25. Structure of yeast Dom34: a protein related to translation termination factor Erf1 and involved in No-Go decay.
Graille M; Chaillet M; van Tilbeurgh H
J Biol Chem; 2008 Mar; 283(11):7145-54. PubMed ID: 18180287
[TBL] [Abstract][Full Text] [Related]
26. Role of the individual domains of translation termination factor eRF1 in GTP binding to eRF3.
Kononenko AV; Mitkevich VA; Dubovaya VI; Kolosov PM; Makarov AA; Kisselev LL
Proteins; 2008 Feb; 70(2):388-93. PubMed ID: 17680691
[TBL] [Abstract][Full Text] [Related]
27. Ribosome-bound Pub1 modulates stop codon decoding during translation termination in yeast.
Urakov VN; Mitkevich OV; Safenkova IV; Ter-Avanesyan MD
FEBS J; 2017 Jun; 284(12):1914-1930. PubMed ID: 28467675
[TBL] [Abstract][Full Text] [Related]
28. Yeast polypeptide chain release factors eRF1 and eRF3 are involved in cytoskeleton organization and cell cycle regulation.
Valouev IA; Kushnirov VV; Ter-Avanesyan MD
Cell Motil Cytoskeleton; 2002 Jul; 52(3):161-73. PubMed ID: 12112144
[TBL] [Abstract][Full Text] [Related]
29. Eukaryotic release factor 3 is required for multiple turnovers of peptide release catalysis by eukaryotic release factor 1.
Eyler DE; Wehner KA; Green R
J Biol Chem; 2013 Oct; 288(41):29530-8. PubMed ID: 23963452
[TBL] [Abstract][Full Text] [Related]
30. [Influence of individual domains of the translation termination factor eRF1 on induction of the GTPase activity of the translation termination factor eRF3].
Dubovaia VI; Kolosov PM; Alkalaeva EZ; Frolova LIu; Kiselev LL
Mol Biol (Mosk); 2006; 40(2):310-6. PubMed ID: 16637272
[TBL] [Abstract][Full Text] [Related]
31. Exploring contacts of eRF1 with the 3'-terminus of the P site tRNA and mRNA stop signal in the human ribosome at various translation termination steps.
Bulygin KN; Graifer DM; Hountondji C; Frolova LY; Karpova GG
Biochim Biophys Acta Gene Regul Mech; 2017 Jul; 1860(7):782-793. PubMed ID: 28457996
[TBL] [Abstract][Full Text] [Related]
32. Distinct eRF3 requirements suggest alternate eRF1 conformations mediate peptide release during eukaryotic translation termination.
Fan-Minogue H; Du M; Pisarev AV; Kallmeyer AK; Salas-Marco J; Keeling KM; Thompson SR; Pestova TV; Bedwell DM
Mol Cell; 2008 Jun; 30(5):599-609. PubMed ID: 18538658
[TBL] [Abstract][Full Text] [Related]
33. Depletion in the levels of the release factor eRF1 causes a reduction in the efficiency of translation termination in yeast.
Stansfield I; Eurwilaichitr L; Akhmaloka ; Tuite MF
Mol Microbiol; 1996 Jun; 20(6):1135-43. PubMed ID: 8809766
[TBL] [Abstract][Full Text] [Related]
34. A highly conserved eukaryotic protein family possessing properties of polypeptide chain release factor.
Frolova L; Le Goff X; Rasmussen HH; Cheperegin S; Drugeon G; Kress M; Arman I; Haenni AL; Celis JE; Philippe M
Nature; 1994 Dec; 372(6507):701-3. PubMed ID: 7990965
[TBL] [Abstract][Full Text] [Related]
35. A novel mutant of the Sup35 protein of Saccharomyces cerevisiae defective in translation termination and in GTPase activity still supports cell viability.
Fabret C; Cosnier B; Lekomtsev S; Gillet S; Hatin I; Le Maréchal P; Rousset JP
BMC Mol Biol; 2008 Feb; 9():22. PubMed ID: 18267004
[TBL] [Abstract][Full Text] [Related]
36. Cryo-EM structure of the mammalian eukaryotic release factor eRF1-eRF3-associated termination complex.
Taylor D; Unbehaun A; Li W; Das S; Lei J; Liao HY; Grassucci RA; Pestova TV; Frank J
Proc Natl Acad Sci U S A; 2012 Nov; 109(45):18413-8. PubMed ID: 23091004
[TBL] [Abstract][Full Text] [Related]
37. Cryoelectron microscopic structures of eukaryotic translation termination complexes containing eRF1-eRF3 or eRF1-ABCE1.
Preis A; Heuer A; Barrio-Garcia C; Hauser A; Eyler DE; Berninghausen O; Green R; Becker T; Beckmann R
Cell Rep; 2014 Jul; 8(1):59-65. PubMed ID: 25001285
[TBL] [Abstract][Full Text] [Related]
38. Structure of the mammalian ribosomal pre-termination complex associated with eRF1.eRF3.GDPNP.
des Georges A; Hashem Y; Unbehaun A; Grassucci RA; Taylor D; Hellen CU; Pestova TV; Frank J
Nucleic Acids Res; 2014 Mar; 42(5):3409-18. PubMed ID: 24335085
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of human release factor 1 alone has an antisuppressor effect in human cells.
Le Goff X; Philippe M; Jean-Jean O
Mol Cell Biol; 1997 Jun; 17(6):3164-72. PubMed ID: 9154815
[TBL] [Abstract][Full Text] [Related]
40. [Conservation of the MC domains in eukaryotic termination factor eRF3].
Zhuravleva GA; Zemlianko OM; Le Goff C; Petrova AV; Philippe M; Inge-Vechtomov SG
Genetika; 2007 Jan; 43(1):38-44. PubMed ID: 17333937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
